[Federal Register Volume 61, Number 43 (Monday, March 4, 1996)]
[Notices]
[Page 8303]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 96-4944]



-----------------------------------------------------------------------


DEPARTMENT OF JUSTICE

Manufacturer of Controlled Substances; Notice of Application

    Pursuant to Section 1301.43(a) of Title 21 of the Code of Federal 
Regulations (CFR), this is notice that on November 13, 1995, Johnson 
Matthey, Inc., Custom Pharmaceuticals Department, 2003 Nolte Drive, 
West Deptford, New Jersey 08066, made application to the Drug 
Enforcement Administration (DEA) for registration as a bulk 
manufacturer of the basic classes of controlled substances listed 
below:

------------------------------------------------------------------------
                    Drug                               Schedule         
------------------------------------------------------------------------
2,5-Dimethoxyamphetamine (7396).............     I                      
Difenoxin (9168)............................     I                      
Methylphenidate (1724)......................     II                     
Codeine (9050)..............................     II                     
Oxycodone (9143)............................     II                     
Hydromorphone (9150)........................     II                     
Diphenoxylate (9170)........................     II                     
Hydrocodone (9193)..........................     II                     
Levorphanol (9220)..........................     II                     
Meperidine (9230)...........................     II                     
Meperidine intermediate-A (9232)............     II                     
Meperidine intermediate-B (9233)............     II                     
Meperidine intermediate-C (9234)............     II                     
Methadone (9250)............................     II                     
Methadone intermediate (9254)...............     II                     
Oxymorphone (9652)..........................     II                     
Morphine (9300).............................     II                     
Oxymorphone (9652)..........................     II                     
Sufentanil (9740)...........................     II                     
Carfentanil (9743)..........................     II                     
Fentanyl (9801).............................     II                     
------------------------------------------------------------------------

    The firm plans to manufacture the listed controlled substances in 
bulk to supply final dosage form manufacturers.
    Any other such applicant and any person who is presently registered 
with DEA to manufacture such substances may file comments or objections 
to the issuance of the above application.
    Any such comments or objections may be addressed, in quintuplicate, 
to the Deputy Assistant Administrator, Office of Diversion Control, 
Drug Enforcement Administration, United States Department of Justice, 
Washington, DC 20537, Attention: DEA Federal Register Representative 
(CCR), and must be filed no later than May 3, 1996.

    Dated: February 26, 1996.
Gene R. Haislip,
Deputy Assistant Administrator, Office of Diversion Control, Drug 
Enforcement Administration.
[FR Doc. 96-4944 Filed 3-1-96; 8:45 am]
BILLING CODE 4410-09-M